Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis

Volume: 36, Issue: 6, Pages: 1097 - 1103
Published: Oct 2, 2020
Abstract
Patients undergoing dialysis are at risk of hepatocellular carcinoma (HCC) and preferably should undergo HCC surveillance. We investigated the utility of HCC tumor markers for HCC surveillance in patients undergoing dialysis.Three serum markers specific for HCC, namely alpha-fetoprotein (AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3) and des-gamma-carboxy prothrombin (DCP), were measured in dialysis patients with and without...
Paper Details
Title
Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis
Published Date
Oct 2, 2020
Volume
36
Issue
6
Pages
1097 - 1103
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.